HAGERMAN ALLISON enters ONCOLYTICS BIOTECH INC with 105.06K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Common Shares
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 105.06K | Direct |
| Total | 105.06K | 105.06K direct |
Stock Option
DirectUnderlying shares
45K
Shares owned
N/A
Exercise price
3.40
Expiration
—
Exercise window
—
Stock Option
DirectUnderlying shares
240K
Shares owned
N/A
Exercise price
1.08
Expiration
—
Exercise window
—
Stock Option
DirectUnderlying shares
7.89K
Shares owned
N/A
Exercise price
2.66
Expiration
—
Exercise window
—
Stock Option
DirectUnderlying shares
250K
Shares owned
N/A
Exercise price
0.99
Expiration
—
Exercise window
—
Stock Option
DirectUnderlying shares
75.60K
Shares owned
N/A
Exercise price
1.13
Expiration
—
Exercise window
—
Stock Option
DirectUnderlying shares
21.70K
Shares owned
N/A
Exercise price
2.76
Expiration
—
Exercise window
—
Stock Option
DirectUnderlying shares
72.80K
Shares owned
N/A
Exercise price
1.91
Expiration
—
Exercise window
—
Stock Option
DirectUnderlying shares
80K
Shares owned
N/A
Exercise price
2.31
Expiration
—
Exercise window
—
Underlying
792.99K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option Direct | Common Shares | 3.40 | — | — | 45K | N/A |
| Stock Option Direct | Common Shares | 1.08 | — | — | 240K | N/A |
| Stock Option Direct | Common Shares | 2.66 | — | — | 7.89K | N/A |
| Stock Option Direct | Common Shares | 0.99 | — | — | 250K | N/A |
| Stock Option Direct | Common Shares | 1.13 | — | — | 75.60K | N/A |
| Stock Option Direct | Common Shares | 2.76 | — | — | 21.70K | N/A |
| Stock Option Direct | Common Shares | 1.91 | — | — | 72.80K | N/A |
| Stock Option Direct | Common Shares | 2.31 | — | — | 80K | N/A |
| Total | 792.99K | 0.00 | ||||